Martin Shkreli is convicted of fraudStaff Writer |
Pharma industry Jurors found Shkreli guilty
Former drug company executive Martin Shkreli was convicted of securities fraud by jurors in a U.S. court in Brooklyn, after a highly publicized, monthlong trial.
Jurors found Shkreli guilty on two counts of securities fraud and one count of conspiracy, on the fifth day of deliberations. Shkreli was also found not guilty on five other conspiracy counts.
Before going on trial, Shkreli had been best known for raising the price of anti-infection drug Daraprim by 5,000 percent in 2015 as chief executive of Turing Pharmaceuticals
That increase sparked outrage from U.S. lawmakers and patients, and earned Shkreli the nickname "Pharma bro." ■
What to read next